Samsung Medical Center

🇰🇷South Korea

Country: 🇰🇷South Korea

Ownership: Subsidiary

Established: 1994-01-01

Employees: 501

Market Cap: -

Website: http://www.samsunghospital.com

Clinical Trials

Comparison of Autologous Platelet-rich Plasma With Hyaluronic Acid for the Treatment of Osteoarthritis of the Knee Joint

Phase 3

Completed

Conditions: Osteoarthritis, Knee

Interventions: Biological: PRP
Drug: Hyaluronic acid

First Posted Date: 2014-08-07

Last Posted Date: 2015-12-10

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 110

Registration Number: NCT02211521

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Tolerance Induction in Living Donor Kidney Transplantation With Hematopoietic Stem Cell Transplantation

Not Applicable

Conditions: End Stage Renal Disease

Interventions: Procedure: Transplantation Conditioning for BMT

First Posted Date: 2014-07-24

Last Posted Date: 2014-07-24

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 6

Registration Number: NCT02199301

Locations: 🇰🇷
Samsung Medical Center, Organ Transplant Center, Seoul, Korea, Republic of

Modified Angled Tube vs. Conventional Angled Tube in Double-lumen Endotracheal Tube Intubation

Not Applicable

Completed

Conditions: Intubation, Intratracheal
Thoracic Surgical Procedures

Interventions: Device: Mallinckrodt endotracheal tube with a modified angle
Device: Mallinckrodt endobronchial tube with a conventional angle

First Posted Date: 2014-07-15

Last Posted Date: 2015-02-24

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 108

Registration Number: NCT02190032

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Capecitabine Plus Simvastatin in Locally Advanced Rectal Cancer Patients

Phase 2

Conditions: Adenocarcinoma of Rectum

Interventions: Drug: simvastatin

First Posted Date: 2014-06-12

Last Posted Date: 2020-03-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 60

Registration Number: NCT02161822

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

A Study on Improved Dynamic Myocardial Perfusion With Less Effective Radiation Dose in CT (SIMPLE CT)

Not Applicable

Completed

Conditions: Myocardial Ischemia

Interventions: Procedure: Myocardial CT perfusion

First Posted Date: 2014-06-11

Last Posted Date: 2017-12-06

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 120

Registration Number: NCT02161081

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Efficacy of Motilitone on Gastric Emptying in Patients With Functional Dyspepsia: Evaluation Using MRI Method

Not Applicable

Conditions: Dyspepsia

Interventions: Drug: Placebo
Drug: motilitone

First Posted Date: 2014-05-30

Last Posted Date: 2014-11-25

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 78

Registration Number: NCT02151708

Locations: 🇰🇷
Department of Medicine, Samsung Medical Center,Sungkyunkwan University School of Medicine, Seoul, Korea, Republic of

Perioperative Inflammation and Breast Cancer Outcome

Phase 3

Conditions: Breast Neoplasms

Interventions: Drug: NSAIDS (ketorolac and ibuprofen)

First Posted Date: 2014-05-19

Last Posted Date: 2014-05-19

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 1568

Registration Number: NCT02141139

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Next pErsonalized Cancer tX With mulTi-omics and Preclinical Model

Completed

Conditions: Metastatic Cancer

First Posted Date: 2014-05-19

Last Posted Date: 2015-12-29

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 895

Registration Number: NCT02141152

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Next Generation pErsonalized tX(Therapy) With Plasma DNA Trial-2 in Refractory Solid Tumors (The NEXT-2 Trial)

Completed

Conditions: Metastatic Gastrointestinal Cancer
Genitourinary Cancer

First Posted Date: 2014-05-16

Last Posted Date: 2022-06-15

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 229

Registration Number: NCT02140463

Locations: 🇰🇷
Samsung Medical Center, Seoul, Korea, Republic of

Clopidogrel Resistance and Embolism in Carotid Artery Stenting

Phase 3

Conditions: Carotid Stenosis

Interventions: Drug: Ticlopidine + Ginko biloba
Drug: Clopidogrel

First Posted Date: 2014-05-08

Last Posted Date: 2017-04-26

Lead Sponsor: Samsung Medical Center

Target Recruit Count: 86

Registration Number: NCT02133989

Locations: 🇰🇷
Oh Young Bang, Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy